Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Novel HIV integrase inhibitors discovered at ViiV Healthcare

Nov. 28, 2017

Vanc set to launch INSTI HIV rapid point-of-care test

Nov. 27, 2017

Novel IDO-1 inhibitors discovered at GlaxoSmithKline

Nov. 27, 2017

FDA approves Juluca, the first two-drug regimen for treatment of HIV-1

Nov. 22, 2017

Phase I results for AAV1 vectored immunoprophylaxis for HIV

Nov. 20, 2017

Viiv conducts first-in-human study of maturation inhibitor GSK-3640254

Nov. 9, 2017

Fostemsavir reduces HIV-1 viral load in heavily treatment-experienced patients

Oct. 30, 2017

Immunocore presents constructs for treating HIV infection and AIDS

Oct. 25, 2017

Population Council initiates phase I study of griffithsin gel for HIV prevention

Oct. 23, 2017

EC approves Symtuza for HIV-1 in adolescents and adults, NDA filed in U.S.

Sep. 26, 2017

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...